Adaptive Sample Size Re-Estimation is a statistical methodology in clinical trial design that permits the modification of the planned sample size based on interim analyses of accumulating data, while preserving the trial's integrity and controlling type I error rates.
26
Publications
1.1K
Citations
97
Authors
80
Institutions
Publications per year
2017–2026
4
Parents
Publications
26
1–5 of 26
Authors
97
- CR
5
h-index
- SW
2
h-index
- BW
2
h-index
- CJ
2
h-index
- HH
2
h-index
1–5 of 97
Institutions
80
Harvard University
Cambridge, United States
5 h-index
6 publications
676 citations
Cytel (United States)
Cambridge, United States
5 h-index
6 publications
572 citations
United States Food and Drug Administration
Silver Spring, United States
3 h-index
5 publications
111 citations
Cancer Research And Biostatistics
Seattle, United States
2 h-index
4 publications
103 citations
University of Bath
Bath, United Kingdom
2 h-index
2 publications
72 citations
Cornell University
Ithaca, United States
2 h-index
2 publications
72 citations
Vertex Pharmaceuticals (United States)
Boston, United States
1 h-index
1 publications
14 citations
Geelong Hospital
Geelong, Australia
1 h-index
1 publications
22 citations
1–8 of 80
Venues
- Statistics in Medicine
8 publications · 594 citations
8
h-index
- Journal of Biopharmaceutical Statistics
JBS · 5 publications · 198 citations
5
h-index
- Pharmaceutical Statistics
4 publications · 108 citations
4
h-index
- Drug Information Journal
DIA · 2 publications · 63 citations
2
h-index
- BMC Medical Research Methodology
2 publications · 30 citations
2
h-index
1–5